249 related articles for article (PubMed ID: 20065162)
21. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system.
Mergia E; Friebe A; Dangel O; Russwurm M; Koesling D
J Clin Invest; 2006 Jun; 116(6):1731-7. PubMed ID: 16614755
[TBL] [Abstract][Full Text] [Related]
22. Are the mechanisms for NO-dependent vascular remodeling different from vasorelaxation in vivo?
Schleicher M; Sessa WC
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1207-8. PubMed ID: 18565841
[No Abstract] [Full Text] [Related]
23. Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis.
Lukowski R; Weinmeister P; Bernhard D; Feil S; Gotthardt M; Herz J; Massberg S; Zernecke A; Weber C; Hofmann F; Feil R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1244-50. PubMed ID: 18420996
[TBL] [Abstract][Full Text] [Related]
24. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle.
Gerzanich V; Ivanov A; Ivanova S; Yang JB; Zhou H; Dong Y; Simard JM
Circ Res; 2003 Oct; 93(9):805-12. PubMed ID: 14512447
[TBL] [Abstract][Full Text] [Related]
26. Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase.
Lies B; Groneberg D; Gambaryan S; Friebe A
Br J Pharmacol; 2013 Sep; 170(2):317-27. PubMed ID: 23763290
[TBL] [Abstract][Full Text] [Related]
27. Ilk conditional deletion in adult animals increases cyclic GMP-dependent vasorelaxation.
Serrano I; De Frutos S; Griera M; Medrano D; Rodríguez-Puyol M; Dedhar S; Ruiz-Torres MP; Rodríguez-Puyol D
Cardiovasc Res; 2013 Aug; 99(3):535-44. PubMed ID: 23715557
[TBL] [Abstract][Full Text] [Related]
28. Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.
Agbor LN; Nair AR; Wu J; Lu KT; Davis DR; Keen HL; Quelle FW; McCormick JA; Singer JD; Sigmund CD
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184598
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle.
Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E
Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling.
Kirsch M; Kemp-Harper B; Weissmann N; Grimminger F; Schmidt HH
FASEB J; 2008 Jan; 22(1):30-40. PubMed ID: 17679609
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension.
Stegbauer J; Friedrich S; Potthoff SA; Broekmans K; Cortese-Krott MM; Quack I; Rump LC; Koesling D; Mergia E
PLoS One; 2013; 8(11):e80674. PubMed ID: 24260450
[TBL] [Abstract][Full Text] [Related]
32. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR; Nakanishi H; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
[TBL] [Abstract][Full Text] [Related]
34. NO-sensitive guanylyl cyclase beta1 subunit is peripherally associated to chromosomes during mitosis. Novel role in chromatin condensation and cell cycle progression.
Pifarré P; Baltrons MA; Földi I; García A
Int J Biochem Cell Biol; 2009; 41(8-9):1719-30. PubMed ID: 19433313
[TBL] [Abstract][Full Text] [Related]
35. Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism.
Chamorro-Jorganes A; Grande MT; Herranz B; Jerkic M; Griera M; Gonzalez-Nuñez M; Santos E; Rodriguez-Puyol D; Lopez-Novoa JM; Rodriguez-Puyol M
Hypertension; 2010 Sep; 56(3):484-9. PubMed ID: 20679183
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
37. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
[TBL] [Abstract][Full Text] [Related]
38. Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.
Sabrane K; Kruse MN; Gazinski A; Kuhn M
Endocrinology; 2009 May; 150(5):2382-7. PubMed ID: 19179430
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
